article thumbnail

Health Provider News – February 18, 2022

Hall Render

Meet new FDA chief Dr. Robert Califf: 5 things to know. Only 14% of Hospitals Met Price Transparency Rule Compliance. Florida physician convicted of $110M fraud. Bill on prescription drug pricing inspires support from Maine residents, opposition from pharmaceutical industry. billing fraud.

article thumbnail

Guest Post – Second Circuit Rejects Manufacturer’s Plan to Share Cost of Expensive Drug with Medicare Part D Beneficiaries

Drug & Device Law

The manufacturer sought to cover Medicare patients’ Part D cost-sharing obligations for the drug – which were estimated at approximately $13,000 per year – but the OIG said “no thanks,” and the Second Circuit has affirmed that outcome. A little background is in order. ATTR-CM only affects about 150,000 Americans, who are mostly elderly.